MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$1,644,224
Unrealized gain on
short-term debt...
$2,893
Net loss
-$1,647,117
Loss before
provision for income taxes
-$1,647,117
Loss from operations
-$1,594,660
Total other income
(expense), net
-$52,457
Interest and dividend
income, net
$38,718
Staking income on crypto
assets
$191
Total operating
expenses
$1,591,998
Gross (loss) profit
-$2,662
Unrealized loss on crypto
assets, at fair value
-$53,348
License fee revenue
$18,026
Impairment loss on crypto
assets, at cost
-$29,911
Interest expense
$3,373
Foreign currency
transaction loss
-$2,674
Unrealized loss on
short-term tokenized...
-$2,060
Research and development
$1,013,265
Professional fees
$255,293
Compensation expense
$242,633
Other selling,
general and...
$80,807
Cost of revenues
$20,688
Back
Back
Income Statement
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)
source: myfinsight.com